Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
- Status
- RECRUITING
- Phase
- NA
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Impact of "No-touch" Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)
- Status
- RECRUITING
- Phase
- PHASE2
Pharmacogenetic of Doxorubicin in HCC.
- Status
- COMPLETED
- Phase
- N/A
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Open Versus Laparoscopic Ablation of Liver Malignancies
- Status
- RECRUITING
- Phase
- NA
Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling
- Status
- COMPLETED
- Phase
- N/A
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
- Status
- RECRUITING
- Phase
- NA